Form 4: IGM Biosciences Chief Scientific Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Bruce Keyt, Chief Scientific Officer of IGM Biosciences, sold 1,487 shares of common stock on September 13, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On September 13, 2024, Bruce Keyt, the Chief Scientific Officer of IGM Biosciences, sold 1,487 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $11.5388, with individual trades ranging from $11.20 to $11.795.
- Following the transaction, Keyt directly owns 242,948 shares and indirectly owns 4,039 shares through his spouse.
Sentiment
Score: 5
Explanation: The document describes a routine stock sale to cover tax obligations, which is neither particularly positive nor negative.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when restricted stock units vest.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the context.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Date of the stock sale transaction. |
| 09/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.